Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.825 USD | +0.83% | +1.67% | -3.68% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
Evolution of the average Target Price on I-Mab
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering I-Mab
Piper Sandler | |
Needham & Co. | |
HC Wainwright | |
SWS Research | |
Cantor Fitzgerald | |
Daiwa Securities |
EPS Revisions
- Stock Market
- Equities
- IMAB Stock
- Consensus I-Mab